<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05010746</url>
  </required_header>
  <id_info>
    <org_study_id>INVL20-01-IT</org_study_id>
    <nct_id>NCT05010746</nct_id>
  </id_info>
  <brief_title>TVMR With the Innovalve System Trial - Pilot Study in Italy</brief_title>
  <acronym>TWIST-PILOT-IT</acronym>
  <official_title>TVMR With the Innovalve System Trial - Pilot Study in Italy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Innovalve Bio Medical Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Innovalve Bio Medical Ltd.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study to evaluate the safety and performance of the Innovalve mitral valve replacement system&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2021</start_date>
  <completion_date type="Anticipated">October 1, 2027</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Absence of implant or delivery related serious adverse events at 30 days</measure>
    <time_frame>30 days</time_frame>
    <description>Absence of implant or delivery related serious adverse events at 30 days</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Mitral Valve Regurgitation (Degenerative or Functional)</condition>
  <arm_group>
    <arm_group_label>MV replacement with Innovalve MR system</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>MV replacement with Innovalve MR system</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Innovalve TMVR system</intervention_name>
    <description>Innovalve TMVR system</description>
    <arm_group_label>MV replacement with Innovalve MR system</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinically significant, symptomatic mitral regurgitation&#xD;
&#xD;
          -  High risk for open-heart surgery&#xD;
&#xD;
          -  Meets anatomical criteria&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unsuitable anatomy&#xD;
&#xD;
          -  Patient is inoperable&#xD;
&#xD;
          -  EF &lt;30%&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 11, 2021</study_first_submitted>
  <study_first_submitted_qc>August 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 18, 2021</study_first_posted>
  <last_update_submitted>August 11, 2021</last_update_submitted>
  <last_update_submitted_qc>August 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitral Valve Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

